Salarius Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Salarius Pharmaceuticals has a total shareholder equity of $2.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $3.6M and $1.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.27m |
| Equity | US$2.38m |
| Total liabilities | US$1.18m |
| Total assets | US$3.55m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: FP10's short term assets ($3.5M) exceed its short term liabilities ($1.2M).
Long Term Liabilities: FP10 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: FP10 is debt free.
Reducing Debt: FP10 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: FP10 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: FP10 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 23.8% each year